Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

Conditions: Keloid Interventions: Drug: Ritlecitinib Sponsors: Icahn School of Medicine at Mount Sinai; Pfizer Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Keloids | Pfizer | Research